University of California San Francisco | About UCSF | UCSF Benioff Children's Hospital San Francisco
Search Site | Find a Doctor

Peter Goadsby, M.B. B.S.

Neurologist and headache specialist

Dr. Peter Goadsby, a neurologist, specializes in the diagnosis and treatment of headache disorders, including migraines and cluster headache and other forms of chronic daily headache. He is director of the UCSF Headache Center and one of the world's leading headache experts and researchers.

Goadsby came to UCSF from the Institute of Neurology at University College London, National Hospital for Neurology and Neurosurgery and Hospital for Sick Children, Great Ormond Street, London, England. His research focuses on the mechanisms and management of head pain, with a special interest in migraine and trigeminal autonomic cephalalgias. His studies aim to understand the parts of the brain involved in headache and from this to derive new approaches to treatment. He earned a medical degree at the University of New South Wales School of Medicine, completed a residency in neurology at the Prince of Wales Hospital and completed a fellowship in neurology at the National Hospital for Nervous and Mental Diseases in London. He completed post-doctoral work in laboratories in New York and Paris.


Headache Center
1701 Divisadero St., Suite 480
San Francisco, CA 94115
Phone: (415) 353-8393
Fax: (415) 353-9539

Hours: Monday to Friday
9 a.m. – 5 p.m.

Conditions & Treatments

More about Peter Goadsby


University of New South Wales Doctorate Program, Neurosciences 1983
University of New South Wales School of Medicine 1985


Prince Henry, Prince of Wales Hospital, Medicine 1987
Prince Henry, Prince of Wales Hospital, Neurology 1988
Prince Henry, Prince of Wales Hospital, Clinical Neurophysiology 1989


National Hospital for Nervous and Mental Diseases, Neurology 1990

Selected Research and Publications

  1. Al-Hashel JY, Ahmed SF, Alroughani R, Goadsby PJ. Migraine misdiagnosis as a sinusitis, a delay that can last for many years. J Headache Pain. 2013; 14(1):97.
  2. Akerman S, Holland PR, Lasalandra MP, Goadsby PJ. Endocannabinoids in the brainstem modulate dural trigeminovascular nociceptive traffic via CB1 and "triptan" receptors: implications in migraine. J Neurosci. 2013 Sep 11; 33(37):14869-77.
  3. Simpson JC, Goadsby PJ, Prabhakar P. Positive persistent visual symptoms (visual snow) presenting as a migraine variant in a 12-year-old girl. Pediatr Neurol. 2013 Nov; 49(5):361-3.
  4. Goadsby PJ. The last two years. Cephalalgia. 2013 Jul; 33(10):811-2.
  5. Goadsby PJ. Author's reply on Pathophysiology of migraine. Ann Indian Acad Neurol. 2013 Jul; 16(3):456-7.
  6. Sanderson JC, Devine EB, Lipton RB, Bloudek LM, Varon SF, Blumenfeld AM, Goadsby PJ, Buse DC, Sullivan SD. Headache-related health resource utilisation in chronic and episodic migraine across six countries. J Neurol Neurosurg Psychiatry. 2013 Dec; 84(12):1309-17.
  7. Gelfand AA, Reider AC, Goadsby PJ. Cranial autonomic symptoms in pediatric migraine are the rule, not the exception. Neurology. 2013 Jul 30; 81(5):431-6.
  8. Hoffmann J, Goadsby PJ. Update on intracranial hypertension and hypotension. Curr Opin Neurol. 2013 Jun; 26(3):240-7.
  9. Wilbrink LA, Teernstra OP, Haan J, van Zwet EW, Evers SM, Spincemaille GH, Veltink PH, Mulleners W, Brand R, Huygen FJ, Jensen RH, Paemeleire K, Goadsby PJ, Visser-Vandewalle V, Ferrari MD. Occipital nerve stimulation in medically intractable, chronic cluster headache. The ICON study: rationale and protocol of a randomised trial. Cephalalgia. 2013 Nov; 33(15):1238-47.
  10. Maniyar FH, Goadsby PJ. Functional imaging in chronic migraine. Curr Pain Headache Rep. 2013 May; 17(5):333.
  11. Goadsby PJ. All that is obvious is not clear: what is the origin of throbbing pain in migraine? Pain. 2013 Jul; 154(7):970-1.
  12. Goadsby PJ. Sphenopalatine (pterygopalatine) ganglion stimulation and cluster headache: new hope for ye who enter here. Cephalalgia. 2013 Jul; 33(10):813-5.
  13. Viana M, Genazzani AA, Terrazzino S, Nappi G, Goadsby PJ. Triptan nonresponders: do they exist and who are they? Cephalalgia. 2013 Aug; 33(11):891-6.
  14. Viana M, Sprenger T, Andelova M, Goadsby PJ. The typical duration of migraine aura: a systematic review. Cephalalgia. 2013 May; 33(7):483-90.
  15. Gantenbein AR, Sandor PS, Fritschy J, Turner R, Goadsby PJ, Kaube H. Sensory information processing may be neuroenergetically more demanding in migraine patients. Neuroreport. 2013 Mar 6; 24(4):202-5.
  16. Eller M, Goadsby PJ. MRI in headache. Expert Rev Neurother. 2013 Mar; 13(3):263-73.
  17. Asano E, Goadsby PJ. How do we fashion better trials for neurostimulator studies in migraine? Neurology. 2013 Feb 19; 80(8):694.
  18. Afridi SK, Giffin NJ, Kaube H, Goadsby PJ. A randomized controlled trial of intranasal ketamine in migraine with prolonged aura. Neurology. 2013 Feb 12; 80(7):642-7.
  19. Goadsby PJ, Silberstein SD. Migraine triggers: harnessing the messages of clinical practice. Neurology. 2013 Jan 29; 80(5):424-5.
  20. Storer RJ, Goadsby PJ. Topiramate is likely to act outside of the trigeminocervical complex. Cephalalgia. 2013 Apr; 33(5):291-300.

Publications are derived from MEDLINE/PubMed and provided by UCSF Profiles, a service of the Clinical & Translational Science Institute (CTSI) at UCSF. Researchers can make corrections and additions to their publications by logging on to UCSF Profiles.